Related Experiment Videos
[Epidemiologic and serologic studies of pneumococcal infections with reference to the new STIKO recommendations]
C Hülsse1, M Littmann, K Fiedler
1Landeshygieneinstitut Rostock.
Abstract:
Pneumococcal diseases play an important role especially for babies and toddlers (otitis media) and for older persons (pneumonia). 28% of the 481 reported cases of bacterial meningitides (without meningococcus) in Mecklenburg-Vorpommern were caused by pneumoniae streptococcus. A pneumococcus antibody study by the land register confirms the high contamination in older people. Therefore STIKO recommends since March 1998 to effect pneumococcal vaccination with every person from the age of 60 and dove as well as for children, adolescents and adults with higher risk due to a primary disease.
Insights
Pneumococcal diseases, including pneumonia and meningitis, significantly impact infants and the elderly. Vaccination is recommended for individuals over 60 and high-risk groups due to high disease prevalence.
Area of Science:
- Infectious Diseases
- Bacteriology
- Immunology
Context:
- Pneumococcal diseases pose significant health risks, particularly otitis media in infants and pneumonia in the elderly.
- Streptococcus pneumoniae was responsible for 28% of reported bacterial meningitis cases (excluding meningococcus) in Mecklenburg-Vorpommern.
- A pneumococcus antibody study confirmed high infection rates in the elderly population.
Purpose:
- To highlight the public health burden of pneumococcal diseases.
- To underscore the importance of pneumococcal vaccination based on epidemiological data and expert recommendations.
Summary:
- Pneumococcal diseases are a major concern for young children and older adults.
- Data from Mecklenburg-Vorpommern shows Streptococcus pneumoniae as a leading cause of bacterial meningitis.
- Studies indicate a high prevalence of pneumococcal antibodies in older individuals, necessitating preventive measures.
Impact:
- The findings support the Standing Committee on Vaccination (STIKO) recommendation for pneumococcal vaccination.
- Vaccination is advised for all individuals aged 60 and above, as well as for at-risk children, adolescents, and adults.
- Public health strategies should focus on increasing vaccination rates in vulnerable populations to reduce disease burden.